Chargement en cours...
Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
Recurrent major depressive disorder (rMDD) is a relapsing-remitting disease with high morbidity and a 5-year risk of recurrence of up to 80%. This was a prospective pilot study to examine the potential diagnostic and prognostic value of targeted plasma metabolomics in the care of patients with rMDD...
Enregistré dans:
| Publié dans: | Transl Psychiatry |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group UK
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7801396/ https://ncbi.nlm.nih.gov/pubmed/33431800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-020-01182-w |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|